forecast
Survival gap attributed to insufficient field intensity
The reason five-year survival is not near 80 percent is that the field dose is still too low, and preclinical animal models suggest the tumors could be killed with higher dose, so engineering higher intensity is the company's path forward.
forecastpending
Speaker
BillEvidence Quote
“we can kill all these tumors. We just need to get the dose higher”
Created: 11/19/2026, 2:27:17 AM
Your notes
Loading notes...